First Human Embryonic Stem Cell Trial Begins
The landmark trial could one day lead to a breakthrough in the treatment of spinal cord injuries.
Doctors have begun the first tests of human embryonic stem cells in patients, treating a man with spinal cord injuries in a landmark trial of the controversial process, the Geron Corporation said Monday.
The patient began the pioneering treatment Friday with an injection of the biotech company’s human embryonic stem cells, as part of a clinical trial that aims to test safety and efficacy toward regaining sensation and movement.
The treatment took place at the Shepherd Center in Atlanta, Georgia, a spokeswoman for the hospital told AFP, declining to give further details due to patient privacy concerns.
The Phase I trial is expected to involve around 10 patients. Participants in the human trials must be severely injured and start treatment with Geron’s product, GRNOPC1, seven to 14 days after sustaining their injury.
Best of luck to all involved. I truly hope they succeed.